Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) active agents. Its structure supports the design of compounds with dopaminergic and serotonergic activity, making it valuable in researching treatments for neurological disorders such as Parkinson’s disease and depression. The trifluoromethyl group enhances metabolic stability and bioavailability, which improves drug performance. It is also employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its rigid framework and ability to mimic bioactive conformations.